Clinical Trials Directory

Trials / Completed

CompletedNCT05093751

Automated Segmentation and Volumetry for Meningioma Using Deep Learning

Automated Meningioma Segmentation and Volumetry Using a nnU-Net Based Architecture on Contrast-enhanced MRI

Status
Completed
Phase
Study type
Observational
Enrollment
600 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

U-Net-based architectures will be applied to 500 contrast-enhanced axial MR images of different patients from a single institution after manual segmentation of meningioma, of which 50 were used for testing. Tumor volumetry after autosegmentation by trained U-Net-based architecture is final goal.

Detailed description

U-Net-based architectures will be applied to 500 contrast-enhanced axial MR images of different patients from a single institution after manual segmentation of meningioma, of which 50 were used for testing. After preprocessing with Z-isotropification and intensity normalization of images, 3 U-Net-based networks (2D U-Net, Attention U-Net, 3D U-Net) and 3 nnU-Net-based networks (2D nnU-Net, Attention nnU-Net, 3D nnU-Net) will be trained with meningioma-segmented images. For applying to 3D networks, sagittal and coronal images will be reconstructed using axial images. After prediction, the cut-off of the probability function, which is a trade-off, will be obtained with the Gaussian Mixture Modeling algorithm using the probability density function. The voxels having a probability function higher than that will be finally predicted as meningioma. Tumor volume is calculated as the sum of the product of segmented area and thickness of axial images. For performance evaluation, dice similarity coefficient (DSC), precision, and recall will be evaluated compared with manually segmented voxels for validation datasets. The results of volumetry of each model will be compared with manual segmentation-based volume through Pearson's correlation analysis.

Conditions

Interventions

TypeNameDescription
OTHERObservationThis study does not involve any intervention to subjects.

Timeline

Start date
2013-03-23
Primary completion
2021-09-30
Completion
2021-09-30
First posted
2021-10-26
Last updated
2021-10-26

Source: ClinicalTrials.gov record NCT05093751. Inclusion in this directory is not an endorsement.